The Impact of Marijuana Use on Postoperative Outcomes in Abdominal-based Free Flap Breast Reconstruction

 

 Buy Article Permissions and Reprints

Abstract

Background There is an increasing prevalence of marijuana use in the general population yet clinical studies on marijuana's effect on surgical outcomes remain limited. Marijuana's effect on wound healing, venous thromboembolism (VTE) due to endothelial inflammation, and bleeding due to inhibited platelet function have been cited based on animal models but have not been evaluated clinically in patients undergoing microsurgical reconstruction.

Methods Retrospective chart review was performed on all patients who underwent abdominal-based free flap breast reconstruction in a single institute from August 2018 to December 2022. Patient self-reported marijuana use, demographics, total narcotic use during hospitalization converted to oral morphine milligram equivalent (MME), and 90-day complications were collected and compared.

Results A total of 162 patients were included and 13 patients (8.5%) had reported marijuana use on presurgical history. Marijuana users are more likely to be younger and report concurrent nicotine smoking. Marijuana users were also at a significantly elevated risk of developing symptomatic VTE (15 vs. 1%; odds ratio (OR) 13.4 [95% confidence interval (CI) 1.71–104.2]; p = 0.01) and marijuana use remained a significant risk factor with multivariate analysis. On postoperative 90-day complications, there was no increased risk of flap loss, reoperation, postoperative transfusion, or hematoma associated with marijuana use, and no significantly increased risk for overall donor or recipient site complications. Marijuana users required significantly more narcotics for pain control during hospitalization (100 ± 77 vs. 49 ± 45 MME; p = 0.0003), although they had similar lengths of stay, achievement of mobilization on post operative day (POD)1, and maximal pain scores.

Conclusion Marijuana use increases the risks of postoperative VTE and increased postoperative narcotic requirements in patients who underwent abdominal-based free flap breast reconstruction. Future prospective cohort study is required to further understand marijuana-associated risks in microsurgical procedures.

Publication History

Received: 26 December 2023

Accepted: 23 February 2024

Accepted Manuscript online:
27 February 2024

Article published online:
28 March 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Potnuru PP, Jonna S, Williams II GW. Cannabis use disorder and perioperative complications. JAMA Surg 2023; 158 (09) 935-944
  CrossrefPubMedGoogle Scholar
• 2 Oster B, Hameed D, Bains SS. et al. Tobacco and cannabis use have a synergistic association on infection risk following total knee arthroplasty. J Arthroplasty 2023; 38 (10) 2137-2141
  CrossrefPubMedGoogle Scholar
• 3 Raso J, Althoff A, Brunette C, Kamalapathy P, Arney M, Werner BC. Preoperative substance use disorder is associated with an increase in 90-day postoperative complications, 1-year revisions and conversion to arthroplasty following arthroscopic rotator cuff repair: substance use disorder on the rise. Arthroscopy 2023; 39 (06) 1386-1393.e4
  CrossrefPubMedGoogle Scholar
• 4 Chiu RG, Fuentes AM, Patil SN, Chiu R, McGuire LS, Mehta AI. Cannabis abuse and perioperative complications after treatment of intracranial aneurysms: a nationwide analysis. World Neurosurg 2022; 158: e184-e195
  CrossrefPubMedGoogle Scholar
• 5 Goel A, McGuinness B, Jivraj NK. et al. Cannabis use disorder and perioperative outcomes in major elective surgeries: a retrospective cohort analysis. Anesthesiology 2020; 132 (04) 625-635
  CrossrefPubMedGoogle Scholar
• 6 Braet DJ, Albright J, Brown C, Osborne NH, Henke PK. Impact of cannabis use on outcomes after lower extremity bypass. Ann Vasc Surg 2023; 89: 43-51
  CrossrefPubMedGoogle Scholar
• 7 Teven CM, Song DH. Times are a changin': marijuana use among plastic surgery patients. Plast Reconstr Surg 2021; 148 (04) 702e-704e
  CrossrefPubMedGoogle Scholar
• 8 Copeland-Halperin LR, Herrera-Gomez LC, LaPier JR, Shank N, Shin JH. The effects of cannabis: implications for the surgical patient. Plast Reconstr Surg Glob Open 2021; 9 (03) e3448
  CrossrefPubMedGoogle Scholar
• 9 Garoosi K, Lee N, Tuano KR. et al. Analysis of complications in patients with a history of cannabis use and tobacco use undergoing implant-based breast reconstruction. Aesthet Surg J 2023; 44 (01) NP41-NP48
  CrossrefPubMedGoogle Scholar
• 10 Oleru OO, Seyidova N, Mai D, Taub PJ. Cannabis use and flap reconstruction: a propensity score matched analysis. Microsurgery 2023; 43 (08) 865-867
  CrossrefPubMedGoogle Scholar
• 11 Latif Z, Garg N. The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use. J Clin Med 2020; 9 (06) 1925
  CrossrefPubMedGoogle Scholar
• 12 Middlekauff HR, Cooper ZD, Strauss SB. Drugs of misuse: focus on vascular dysfunction. Can J Cardiol 2022; 38 (09) 1364-1377
  CrossrefPubMedGoogle Scholar
• 13 Weiss MC, Hibbs J, McHugh TW. et al. A survey of breast cancer patients' use of cannabis before, during, and after treatment. J Clin Orthod 2020; 38 (15) e19210
  PubMedGoogle Scholar
• 14 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  CrossrefPubMedGoogle Scholar
• 15 Pannucci CJ, Bailey SH, Dreszer G. et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 2011; 212 (01) 105-112
  CrossrefPubMedGoogle Scholar
• 16 Lu YH, Jeon J, Mahajan L, Yan Y, Weichman KE, Ricci JA. Postoperative magnesium sulfate repletion decreases narcotic use in abdominal-based free flap breast reconstruction. J Reconstr Microsurg 2024; (e-pub ahead of print). DOI: 10.1055/a-2253-9008.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022; 71 (03) 1-95
  CrossrefPubMedGoogle Scholar
• 18 Edalatpour A, Attaluri P, Larson JD. Medicinal and recreational marijuana: review of the literature and recommendations for the plastic Surgeon. Plast Reconstr Surg Glob Open 2020; 8 (05) e2838
  CrossrefPubMedGoogle Scholar
• 19 Huson HB, Granados TM, Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon 2018; 4 (09) e00779
  CrossrefPubMedGoogle Scholar
• 20 Cone Jr JD, Harrington MA, Kelley SS, Prince MD, Payne WG, Smith Jr DJ. Drug abuse in plastic surgery patients: optimizing detection and minimizing complications. Plast Reconstr Surg 2011; 127 (01) 445-455
  CrossrefPubMedGoogle Scholar
• 21 Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg 2004; 99 (04) 1127-1130
  CrossrefPubMedGoogle Scholar
• 22 Stupinski J, Bible L, Asmar S. et al. Impact of marijuana on venous thromboembolic events: cannabinoids cause clots in trauma patients. J Trauma Acute Care Surg 2020; 89 (01) 125-131
  CrossrefPubMedGoogle Scholar
• 23 Turan OA, Rullan PJ, Pasqualini I. et al. Cannabis use following total joint arthroplasty is associated with increased risks? A meta-analysis. J Arthroplasty 2024; 39 (02) 533-540.e6
  CrossrefPubMedGoogle Scholar
• 24 Modarressi A, Schettini AV, Rüegg EM, Pittet-Cuénod B. Venous thromboembolism events after breast reconstructions with DIEP free flaps in 192 consecutive case. Ann Chir Plast Esthet 2018; 63 (01) 11-19
  CrossrefPubMedGoogle Scholar
• 25 Le ELH, Saifee J, Constantine R. et al. Extended venous thromboembolism chemoprophylaxis following microsurgical breast reconstruction: analysis of trends in postoperative anticoagulation. Plast Reconstr Surg 2023; 152 (01) 20-27
  CrossrefPubMedGoogle Scholar
• 26 Subichin MP, Patel NV, Wagner DS. Method of breast reconstruction determines venous thromboembolism risk better than current prediction models. Plast Reconstr Surg Glob Open 2015; 3 (05) e397
  CrossrefPubMedGoogle Scholar
• 27 Qiu CS, Jordan SW, Dorfman RG, Vu MM, Alghoul MS, Kim JYS. Surgical duration impacts venous thromboembolism risk in microsurgical breast reconstruction. J Reconstr Microsurg 2018; 34 (01) 47-58
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Masoomi H, Paydar KZ, Wirth GA, Aly A, Kobayashi MR, Evans GRD. Predictive risk factors of venous thromboembolism in autologous breast reconstruction surgery. Ann Plast Surg 2014; 72 (01) 30-33
  CrossrefPubMedGoogle Scholar
• 29 Fischer JP, Wes AM, Tuggle CT, Wu LC. Venous thromboembolism risk in mastectomy and immediate breast reconstruction: analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets. Plast Reconstr Surg 2014; 133 (03) 263e-273e
  CrossrefPubMedGoogle Scholar
• 30 Pittelkow EM, DeBrock WC, Mailey B. et al. Evaluation of an extended-duration chemoprophylaxis regimen for venous thromboembolism after microsurgical breast reconstruction. Plast Reconstr Surg Glob Open 2021; 9 (08) e3741
  CrossrefPubMedGoogle Scholar
• 31 Felder S, Rasmussen MS, King R. et al. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2019; 8 (08) CD004318
  PubMedGoogle Scholar
• 32 Shaikh MA, Jeong HS, Mastro A, Davis K, Lysikowski J, Kenkel JM. Analysis of the American Society of Anesthesiologists Physical Status Classification System and Caprini Risk Assessment Model in predicting venous thromboembolic outcomes in plastic surgery patients. Aesthet Surg J 2016; 36 (04) 497-505
  CrossrefPubMedGoogle Scholar
• 33 Mensah E, Tabrizchi R, Daneshtalab N. Pharmacognosy and effects of cannabinoids in the vascular system. ACS Pharmacol Transl Sci 2022; 5 (11) 1034-1049
  CrossrefPubMedGoogle Scholar
• 34 Watson CV, Alexander DS, Oliver BE, Trivers KF. Substance use among adult marijuana and nicotine e-cigarette or vaping product users, 2020. Addict Behav 2022; 132: 107349
  CrossrefPubMedGoogle Scholar
• 35 Fernandez AC, Waljee JF, Gunaseelan V, Brummett CM, Englesbe MJ, Bicket MC. Prevalence of unhealthy substance use and associated characteristics among patients presenting for surgery. Ann Surg 2023; 278 (04) e740-e744
  CrossrefPubMedGoogle Scholar
• 36 Yoon Y, Lee N, Lee AD. et al. Analysis of postoperative complications related to cannabis and tobacco usage in patients undergoing mandible facial fracture surgeries. J Plast Reconstr Aesthet Surg 2023; 85: 127-133
  CrossrefPubMedGoogle Scholar
• 37 Livesey MG, Bains SS, Stern JM. et al. Cannabis use in patients with distal radius fractures: a moment of unity?. Hand (N Y) 2023; ; 15589447231196905 DOI: 10.1177/15589447231196905.
  CrossrefPubMedGoogle Scholar
• 38 Temple-Oberle C, Shea-Budgell MA, Tan M. et al; ERAS Society. Consensus Review of Optimal Perioperative Care in Breast Reconstruction: Enhanced Recovery after Surgery (ERAS) Society Recommendations. Plast Reconstr Surg 2017; 139 (05) 1056e-1071e
  CrossrefPubMedGoogle Scholar
• 39 Sebai ME, Siotos C, Payne RM. et al. Enhanced recovery after surgery pathway for microsurgical breast reconstruction: a systematic review and meta-analysis. Plast Reconstr Surg 2019; 143 (03) 655-666
  CrossrefPubMedGoogle Scholar
• 40 Rodnoi P, Teotia SS, Haddock NT. Economic impact of refinements in ERAS pathways in DIEP flap breast reconstruction. J Reconstr Microsurg 2022; 38 (07) 524-529
  Article in Thieme ConnectPubMedGoogle Scholar
• 41 O'Neill A, Lirk P. Multimodal analgesia. Anesthesiol Clin 2022; 40 (03) 455-468
  CrossrefPubMedGoogle Scholar
• 42 Wiseman LK, Mahu IT, Mukhida K. The effect of preoperative cannabis use on postoperative pain following gynaecologic oncology surgery. J Obstet Gynaecol Can 2022; 44 (07) 750-756
  CrossrefPubMedGoogle Scholar
• 43 Bhashyam AR, Heng M, Harris MB, Vrahas MS, Weaver MJ. Self-reported marijuana use is associated with increased use of prescription opioids following traumatic musculoskeletal injury. J Bone Joint Surg Am 2018; 100 (24) 2095-2102
  CrossrefPubMedGoogle Scholar
• 44 Ong CB, Puri S, Lebowitz J. et al. Preoperative cannabis use does not increase opioid utilization following primary total hip arthroplasty in a propensity matched analysis. Arch Orthop Trauma Surg 2023; 143 (06) 3629-3635
  CrossrefPubMedGoogle Scholar
• 45 Bowers NL, Hao KA, Trivedi S. et al. Self-reported cannabis use is not associated with greater opioid use in elective hand surgery patients. Eur J Orthop Surg Traumatol 2023; 33 (05) 1857-1862
  CrossrefPubMedGoogle Scholar
• 46 Hegde V, Bracey DN, Johnson RM, Farsad YY, Dennis DA, Jennings JM. Self-reported cannabis use is associated with a lower rate of persistent opioid use after total joint arthroplasty. Arthroplast Today 2022; 17: 145-149
  CrossrefPubMedGoogle Scholar
• 47 Lee M, Salloum RG, Jenkins W, Hales DB, Sharma A. Marijuana use among US adults with cancer: findings from the 2018-2019 Behavioral Risk Factor Surveillance System. J Cancer Surviv 2023; 17 (04) 1161-1170
  CrossrefPubMedGoogle Scholar
• 48 Rodnoi P, Dickey RM, Teotia SS, Haddock NT. Increased opioid consumption following DIEP flap breast reconstruction: effect of depression and anxiety. J Reconstr Microsurg 2022; 38 (09) 742-748
  Article in Thieme ConnectPubMedGoogle Scholar
• 49 Lenk E, Strecker SE, Nolan W. Multimodal analgesia is superior to opiates alone after tibial fracture in patients with substance abuse history. OTA Int 2022; 5 (04) e214
  CrossrefPubMedGoogle Scholar
• 50 Darville-Beneby R, Lomanowska AM, Yu HC. et al. The impact of preoperative patient education on postoperative pain, opioid use, and psychological outcomes: a narrative review. Can J Pain 2023; 7 (02) 2266751
  CrossrefPubMedGoogle Scholar
• 51 Bamba R, Wiebe JE, Ingersol CA. et al. Do patient expectations of discharge affect length of stay after deep inferior epigastric perforator flap for breast reconstruction?. J Reconstr Microsurg 2022; 38 (01) 34-40
  Article in Thieme ConnectPubMedGoogle Scholar
• 52 Haddock NT, Garza R, Boyle CE, Teotia SS. Observations from implementation of the ERAS Protocol after DIEP Flap Breast Reconstruction. J Reconstr Microsurg 2022; 38 (06) 506-510
  Article in Thieme ConnectPubMedGoogle Scholar
• 53 Zwolinski NM, Patel KS, Vadivelu N, Kodumudi G, Kaye AD. ERAS protocol options for perioperative pain management of substance use disorder in the ambulatory surgical setting. Curr Pain Headache Rep 2023; 27 (05) 65-79
  CrossrefPubMedGoogle Scholar